TipRanks
Annexin Pharmaceuticals AB (SE:ANNX)
:ANNX
Sweden Market
ANNX
Annexin Pharmaceuticals AB
RESEARCH TOOLSreports
Want to see SE:ANNX full AI Analyst Report?

Annexin Pharmaceuticals AB (ANNX) Income Statement

2 Followers

Annexin Pharmaceuticals AB Income Statement

Last quarter (Q2 2026), Annexin Pharmaceuticals AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q2, Annexin Pharmaceuticals AB's net income was kr-11.56M. See Annexin Pharmaceuticals AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr -48.00Kkr -193.00Kkr -193.00Kkr -193.00Kkr -192.00K
Operating Expenses
kr 36.27Mkr 50.48Mkr 44.18Mkr 40.66Mkr 52.83M
Depreciation and Amortization
kr 48.00Kkr 193.00Kkr 193.00Kkr 193.00Kkr 192.00K
EBITDA
kr -36.84Mkr -50.20Mkr -43.86Mkr -40.72Mkr -50.28M
Operating Income
kr -36.31Mkr -50.48Mkr -44.18Mkr -40.72Mkr -51.23M
Other Income/Expenses
kr -580.00Kkr 228.00Kkr 122.00Kkr -70.00Kkr -909.00K
Pretax Income
kr -36.89Mkr -50.25Mkr -44.05Mkr -40.73Mkr -52.14M
Net Income
kr -36.89Mkr -50.25Mkr -44.05Mkr -40.73Mkr -52.14M
Per Share Metrics
Basic EPS
kr -5.58kr -0.11kr -0.26kr -0.17kr -0.39
Diluted EPS
kr -5.58kr -0.11kr -0.26kr -0.17kr -0.39
Weighted Average Shares Outstanding
 6.62M 452.17M 167.11M 241.46M 135.42M
Weighted Average Shares Outstanding (Diluted)
 6.62M 452.17M 167.11M 241.46M 135.42M
Currency in SEK

Annexin Pharmaceuticals AB Earnings and Revenue History